Manulife (Manufacturers Life Insurance)’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.08M Buy
39,965
+3,346
+9% +$557K ﹤0.01% 1119
2026
Q1
$7.68M Sell
36,619
-3,078
-8% -$774K 0.01% 988
2025
Q4
$11.3M Buy
39,697
+144
+0.4% +$45K 0.01% 820
2025
Q3
$12.2M Buy
39,553
+72
+0.2% +$22.6K 0.01% 774
2025
Q2
$12.4M Sell
39,481
-1,361
-3% -$393K 0.01% 756
2025
Q1
$10.7M Sell
40,842
-7,997
-16% -$2.16M 0.01% 802
2024
Q4
$12.8M Sell
48,839
-1,357
-3% -$342K 0.01% 770
2024
Q3
$11.7M Sell
50,196
-5,475
-10% -$1.12M 0.01% 819
2024
Q2
$11.2M Sell
55,671
-763
-1% -$137K 0.01% 792
2024
Q1
$9.67M Sell
56,434
-7,834
-12% -$1.46M 0.01% 873
2023
Q4
$13.9M Sell
64,268
-5,259
-8% -$902K 0.01% 728
2023
Q3
$11.1M Sell
69,527
-2,167
-3% -$485K 0.01% 765
2023
Q2
$20.7M Sell
71,694
-3,127
-4% -$950K 0.01% 583
2023
Q1
$23.9M Buy
74,821
+48,009
+179% +$14.2M 0.01% 552
2022
Q4
$7.91M Buy
26,812
+3,379
+14% +$932K 0.01% 868
2022
Q3
$5.41M Buy
23,433
+946
+4% +$237K ﹤0.01% 1008
2022
Q2
$4.98M Buy
22,487
+994
+5% +$226K ﹤0.01% 1096
2022
Q1
$5.67M Buy
21,493
+20,257
+1,639% +$4.97M ﹤0.01% 1129
2021
Q4
$333 Sell
1,236
-55
-4% -$16K ﹤0.01% 2533
2021
Q3
$367K Hold
1,291
﹤0.01% 2513
2021
Q2
$354K Hold
1,291
﹤0.01% 2689
2021
Q1
$337K Hold
1,291
﹤0.01% 2542
2020
Q4
$330K Hold
1,291
﹤0.01% 2456
2020
Q3
$305K Hold
1,291
﹤0.01% 2287
2020
Q2
$241K Sell
1,291
-171
-12% -$32.7K ﹤0.01% 2400
2020
Q1
$242K Sell
1,462
-26
-2% -$4.75K ﹤0.01% 2210
2019
Q4
$255K Sell
1,488
-66
-4% -$11K ﹤0.01% 2436
2019
Q3
$255K Buy
+1,554
New +$218K ﹤0.01% 2427
2018
Q3
Sell
-1,662
Closed -$142K 3641
2018
Q2
$142K Sell
1,662
-41,280
-96% -$3.7M ﹤0.01% 3321
2018
Q1
$3.72M Sell
42,942
-1,136
-3% -$88.2K ﹤0.01% 1322
2017
Q4
$3.04M Buy
44,078
+20
+0% +$1.31K ﹤0.01% 1355
2017
Q3
$2.43M Sell
44,058
-688
-2% -$37.6K ﹤0.01% 1374
2017
Q2
$2.3M Buy
44,746
+198
+0.4% +$8.6K ﹤0.01% 1404
2017
Q1
$1.92M Buy
44,548
+5,375
+14% +$231K ﹤0.01% 1429
2016
Q4
$1.48M Buy
39,173
+17
+0% +$633 ﹤0.01% 1485
2016
Q3
$1.6M Buy
39,156
+29
+0.1% +$1.15K ﹤0.01% 1431
2016
Q2
$1.18M Buy
39,127
+1,397
+4% +$43.5K ﹤0.01% 1526
2016
Q1
$1.21M Buy
37,730
+488
+1% +$15.3K ﹤0.01% 1532
2015
Q4
$1.41K Buy
37,242
+392
+1% +$13.2K ﹤0.01% 1482
2015
Q3
$955 Buy
36,850
+1,019
+3% +$30.9K ﹤0.01% 1625
2015
Q2
$1.11K Sell
35,831
-720
-2% -$21.2K ﹤0.01% 1632
2015
Q1
$1.22K Buy
36,551
+1,327
+4% +$44.8K ﹤0.01% 1570
2014
Q4
$1.62K Sell
35,224
-842
-2% -$36K ﹤0.01% 1374
2014
Q3
$1.33K Buy
36,066
+956
+3% +$34.9K ﹤0.01% 1426
2014
Q2
$1.39M Sell
35,110
-5,313
-13% -$204K ﹤0.01% 1420
2014
Q1
$1.92K Sell
40,423
-127
-0.3% -$5.62K ﹤0.01% 1347
2013
Q4
$1.5K Sell
40,550
-1,016
-2% -$37.5K ﹤0.01% 1400
2013
Q3
$1.51K Sell
41,566
-1,186
-3% -$39.8K ﹤0.01% 1376
2013
Q2
$1.34M Buy
+42,752
New +$1.21M ﹤0.01% 1342

Other funds holding PODD

Manulife (Manufacturers Life Insurance)'s PODD Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Insulet (PODD) stake by 9.1% in Q2 2026, buying an estimated $557K and bringing the position to 39,965 shares worth $6.08M. The position accounts for ﹤0.01% of the portfolio, ranked #1119.

Manulife (Manufacturers Life Insurance) first reported a position in PODD in Q2 2013 and has held it in 49 quarters since. The position peaked at $23.9M in Q1 2023. 720 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 39,965 shares of Insulet worth $6.08M as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) bought 3,346 Insulet shares in Q2 2026, an estimated $557K.
  • Insulet made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #1119 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Insulet in Q2 2013 and has held it in 49 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Insulet position peaked at $23.9M in Q1 2023.
  • 720 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.